1. United Arab Emirates Diabetes Care Devices Investment
Opportunities, Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 68
Price: Single User License – US$2500
United Arab Emirates Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to
2018
Summary
Global Markets Direct’s new report, “United Arab Emirates Diabetes Care Devices Investment
Opportunities, Analysis and Forecasts to 2018” provides key market data on the United Arab
Emirates Diabetes Care Devices market. The report provides value (USD million), volume (units)
and average price (USD) data for each segment and sub-segment within two market categories –
Glucose Monitoring and Insulin Delivery. The report also provides company shares and
distribution shares data for each of the aforementioned market categories. The report is
supplemented with global corporate-level profiles of the key market participants with information
on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the United Arab Emirates
Diabetes Care Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Bayer HealthCare AG , LifeScan, Inc.,
Abbott Laboratories , Novo Nordisk A/S , Eli Lilly and Company and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Arab Emirates
Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195380-united-arab-emirates-diabetes-care-devices-investment-
opportunities-analysis-and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In United Arab Emirates 8
3.1 Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-
2018 8
3.2 Diabetes Care Devices, United Arab Emirates, Company Share (2010-2011) 14
4 Glucose Monitoring In United Arab Emirates 16
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 16
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 20
4.2 Glucose Monitoring Overall Volume (2004-2018) 22
4.2.1 Blood Glucose Meters, Volume (2004-2018) 26
4.3 Glucose Monitoring Average Price (2004-2018) 28
4.4 Glucose Monitoring Distribution Share (2010-2011) 29
4.5 Glucose Monitoring, United Arab Emirates, Company Share (2010-2011) 30
5 Insulin Delivery In United Arab Emirates 32
5.1 Insulin Delivery Overall Revenue, (2004-2018) 32
5.1.1 Insulin Pens, Revenue (2004-2018) 36
5.1.2 Insulin Pumps, Revenue (2004-2018) 40
5.2 Insulin Delivery Overall Volume (2004-2018) 42
5.2.1 Insulin Pens, Volume (2004-2018) 46
5.2.2 Insulin Pumps, Volume (2004-2018) 50

3. 5.3 Insulin Delivery Average Price (2004-2018) 52
5.4 Insulin Delivery Distribution Share (2010-2011) 53
5.5 Insulin Delivery, United Arab Emirates, Company Share (2010-2011) 54
6 Overview of Key Companies in United Arab Emirates Diabetes Care Devices Market 56
6.1 F. Hoffmann-La Roche Ltd. 56
6.1.1 Company Overview 56
6.2 Abbott Laboratories 56
6.2.1 Company Overview 56
6.3 Bayer HealthCare AG 57
6.3.1 Company Overview 57
6.4 LifeScan, Inc. 57
6.4.1 Company Overview 57
6.5 Novo Nordisk A/S 57
6.5.1 Company Overview 57
6.6 Eli Lilly and Company 58
6.6.1 Company Overview 58
6.7 Sanofi 58
6.7.1 Company Overview 58
6.8 Becton, Dickinson and Company 59
6.8.1 Company Overview 59
6.9 ARKRAY, Inc. 59
6.9.1 Company Overview 59
6.10 Terumo Corporation 60
6.10.1 Company Overview 60
6.11 BIONIME Corporation 60
6.11.1 Company Overview 60
6.12 Medtronic, Inc. 61
6.12.1 Company Overview 61
6.13 Nipro Corporation 61
6.13.1 Company Overview 61
7 Appendix 62
7.1 Global Markets Direct Research Methodology 62
7.2 Definitions of Markets Covered in the Report 63
7.2.1 Diabetes Care Devices 63
7.3 Secondary Research 66
7.4 Primary Research 66
7.5 Models 67
7.6 Forecasts 67
7.7 Expert Panel Validation 67
7.8 Currency Conversion 68
7.9 Contact Us 68
7.10 Disclaimer 68

4. 1.1 List of Tables
Table 1: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
2004-2018 9
Table 2: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
Historic, 2004-2011 11
Table 3: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 13
Table 4: Diabetes Care Devices, United Arab Emirates, Company Share by Revenue ($m), USD
Constant, 2010-2011 15
Table 5: Glucose Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 17
Table 6: Glucose Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 19
Table 7: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m)
USD Constant, Historic, 2004-2011 20
Table 8: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m)
USD Constant, Forecast, 2011-2018 21
Table 9: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-
2011 23
Table 10: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-
2018 25
Table 11: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume
(Units), Historic, 2004-2011 26
Table 12: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume
(Units), Forecast, 2011-2018 27
Table 13: Glucose Monitoring, United Arab Emirates, Average Price ($), Historic, 2004-2011 28
Table 14: Glucose Monitoring, United Arab Emirates, Average Price ($), Forecast, 2011-2018 28
Table 15: Glucose Monitoring, United Arab Emirates, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 29
Table 16: Glucose Monitoring, United Arab Emirates, Company Share by Revenue ($m), USD
Constant, 2010-2011 31
Table 17: Insulin Delivery, United Arab Emirates, Revenue ($m*) USD Constant, by Segment,
Historic, 2004-2011 33
Table 18: Insulin Delivery, United Arab Emirates, Revenue ($m*) USD Constant, by Segment,
Forecast, 2011-2018 35
Table 19: Insulin Pens, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 37
Table 20: Insulin Pens, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 39
Table 21: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($Th) USD
Constant, Historic, 2004-2011 40

5. Table 22: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($Th) USD
Constant, Forecast, 2011-2018 41
Table 23: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-2011
43
Table 24: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-
2018 45
Table 25: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-
2011 47
Table 26: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 49
Table 27: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units),
Historic, 2004-2011 50
Table 28: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units),
Forecast, 2011-2018 51
Table 29: Insulin Delivery, United Arab Emirates, Average Price ($), Historic, 2004-2011 52
Table 30: Insulin Delivery, United Arab Emirates, Average Price ($), Forecast, 2011-2018 52
Table 31: Insulin Delivery, United Arab Emirates, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 53
Table 32: Insulin Delivery, United Arab Emirates, Company Share by Revenue ($m), USD
Constant, 2010-2011 55
1.2 List of Figures
Figure 1: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
2004-2018 8
Figure 2: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
Historic, 2004-2011 10
Figure 3: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 12
Figure 4: Diabetes Care Devices, United Arab Emirates, Company Share (%), 2011 14
Figure 5: Glucose Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 16
Figure 6: Glucose Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 18
Figure 7: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue
($m) USD Constant, Historic, 2004-2011 20
Figure 8: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue
($m) USD Constant, Forecast, 2011-2018 21
Figure 9: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-
2011 22
Figure 10: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Forecast,
2011-2018 24
Figure 11: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume

6. (Units), Historic, 2004-2011 26
Figure 12: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume
(Units), Forecast, 2011-2018 27
Figure 13: Glucose Monitoring, United Arab Emirates, Company Share (%), 2011 30
Figure 14: Insulin Delivery, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 32
Figure 15: Insulin Delivery, United Arab Emirates, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 34
Figure 16: Insulin Pens, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 36
Figure 17: Insulin Pens, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 38
Figure 18: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($Th) USD
Constant, Historic, 2004-2011 40
Figure 19: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($Th) USD
Constant, Forecast, 2011-2018 41
Figure 20: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Historic, 2004-
2011 42
Figure 21: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Forecast, 2011-
2018 44
Figure 22: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2004-
2011 46
Figure 23: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 48
Figure 24: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units),
Historic, 2004-2011 50
Figure 25: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units),
Forecast, 2011-2018 51
Figure 26: Insulin Delivery, United Arab Emirates, Company Share (%), 2011 54
Figure 27: Global Markets Direct Methodology 62
Contact: sales@reportsandreports.com for more information.